Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 27

Trial Status

Completed1
Recruiting1
Terminated3
Other3

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT05020860Phase 2Recruiting
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
Breast CancerBreast Cancer FemaleBreast Cancer Invasive+8 more
PrincipalinvestigatorStart date: 2023-04-18
NCT03324425Phase 2Active Not Recruiting
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
Breast Cancer Stage IV
PrincipalinvestigatorStart date: 2020-03-04
NCT02547987Phase 2Active Not Recruiting
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2015-11-01
NCT01988090Phase 2Terminated
High Dose Vitamin D vs Standard Dose Vitamin D Study
Breast Cancer
PrincipalinvestigatorStart date: 2013-12-01
NCT00999804Phase 2Active Not Recruiting
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Breast Cancer
PrincipalinvestigatorStart date: 2011-10-01
NCT00570323Phase 2Completed
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2007-12-01
NCT02074878Phase 1Terminated
CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer
Breast Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT05020860Phase 2PrincipalInvestigator

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Breast CancerBreast Cancer FemaleBreast Cancer Invasive+8 more
Recruiting
NCT03324425Phase 2PrincipalInvestigator

Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer

Breast Cancer Stage IV
Active Not Recruiting
NCT02547987Phase 2PrincipalInvestigator

Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer

Breast Cancer
Active Not Recruiting
NCT01988090Phase 2PrincipalInvestigator

High Dose Vitamin D vs Standard Dose Vitamin D Study

Breast Cancer
Terminated
NCT00999804Phase 2PrincipalInvestigator

Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy

Breast Cancer
Active Not Recruiting
NCT00570323Phase 2PrincipalInvestigator

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

Breast Cancer
Completed
NCT00817531Phase 2PrincipalInvestigator

Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients

Breast Cancer
Terminated
NCT02074878Phase 1PrincipalInvestigator

CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer

Breast Cancer
Terminated

All 8 trials loaded